Wrocław Dental Implantology Days 2026 (29–31 May) will explain not only how to perform treatment, but why it works. The event will address the most challenging procedures rather than relying solely on safe, schematic approaches; it will confront peri-implantitis honestly — without simplifications; it will teach clinical decision-making instead of protocol copying; and it will integrate hard-tissue surgery with soft-tissue management into one coherent way of thinking. “This is an event for clinicians who want to achieve predictable outcomes even in the most demanding cases,” emphasizes Prof. Marzena Dominiak, Scientific Chair of WDI 2026.
WDI is not only an educational event, but also an expression of the implantology community’s responsibility for treatment quality and patient safety.
WDI teaches decision-making, not protocol replication.
Peri-implantitis is not a marginal issue — it is a test of implantology’s clinical maturity.
Simply browsing the calendar of implantology-focused dental events can be overwhelming. The growing number of conferences means that good organization alone is no longer enough to earn participants’ trust — a clearly defined scientific identity has become essential. What, then, distinguishes Wrocław Dental Implantology Days 2026?
Prof. Marzena Dominiak: We believe that in Wrocław we will be able to address a fundamental question: What does the success of implantological treatment truly depend on today?
WDI 2026 focuses on the key challenges of contemporary implantology: bone regeneration, control of inflammatory response, and the prevention and management of peri-implant complications. The program combines advanced surgical techniques with the biological foundations of their success, with particular emphasis on the role of osteoimmunology in healing and implant integration.
The core topics include vertical and horizontal bone augmentation, regenerative techniques — including IDR and FAST — as well as the conscious selection of treatment protocols across different clinical scenarios, from the posterior mandible to the esthetic zone, with clear indications for immediate and delayed implant placement.
A crucial part of the program is peri-implantitis, discussed in the context of current scientific knowledge, therapeutic limitations, and prevention strategies. WDI 2026 does not avoid difficult topics — it demonstrates where the effectiveness of technique alone ends and where biology, patient selection, and treatment planning begin to determine outcomes.
Who is the WDI program designed for?
Prof. Marzena Dominiak: WDI is a forum for clinically mature implantology — grounded in evidence-based medicine, tissue biology, and a responsible approach to risk. It is intended for clinicians who understand that there is no single universal procedure and that treatment success depends on correct decision-making, proper timing, and an in-depth understanding of biological processes.
In scientific event design, combining expertise from both domestic and international speakers is considered a gold standard — and WDI 2026 follows this principle as well.
However, WDI is not built on rigid templates. As clinicians, we are genuinely interested in how colleagues from Spain, Portugal, France, or Croatia approach similar clinical challenges. Learning through observation reveals differences in educational systems, technological approaches, and sometimes even in patient profiles and etiologies. This exchange enriches everyone — participants and speakers alike.
The WDI 2026 faculty includes Dr Thomas Gemmi, Prof. Eduard Valmaseda-Castellón, Prof. Ricardo Castro Alves, DDS Mariusz Bołzan Castellón, MD, DDS Snjezjana Pohl, MD, PhD Szymon Suwała, MD, PhD Michał Szczutkowski, and MD, PhD Igor Madej, forming a diverse yet coherent platform for discussion on modern implantology, regeneration, and responsible clinical decision-making.
WDI translates the global implantology debate into the realities of everyday clinical practice in Poland. What is discussed internationally as research and theory becomes a practical clinical tool in Wrocław.
Why does WDI place such strong emphasis on biological foundations rather than surgical technique alone?
Prof. Marzena Dominiak: Because predictability begins with biology. WDI demonstrates why treatment works — not just how to perform it — by grounding the program in bone regeneration biology and osteoimmunology. Workshops on vertical and horizontal augmentation focus on immune system interactions with healing processes, inflammatory modulation, rational antibiotic use, PRF protocols, and evidence-based selection of biomaterials. This approach explains why identical techniques may lead to different outcomes in different patients — and why predictability starts with biology, not instruments.
How does WDI differ from events focused primarily on standard “safe” implant procedures?
Prof. Marzena Dominiak: WDI addresses the most challenging procedures rather than relying on safe algorithms. The program includes advanced vertical and horizontal augmentations, extensive bone reconstructions, and regeneration in the posterior mandible while accounting for real anatomical limitations, such as the mental nerve. Beyond technique, we discuss flap design, angiogenesis, space maintenance, and optimal timing for re-entry and implant placement. This is knowledge for clinicians who aim to treat cases at the biological limits safely — not simply repeat low-risk protocols.
Peri-implantitis remains one of the greatest challenges in implantology. What perspective does WDI offer?
Prof. Marzena Dominiak: WDI addresses peri-implantitis honestly — without simplifications — treating it as a real, complex clinical complication rather than a marginal issue. Lectures on peri-implant surgery present both resective and regenerative techniques, discussing their actual outcomes and limitations. Particular emphasis is placed on patient health, correct implant positioning, and long-term maintenance. This perspective shows that effective peri-implantitis control begins at the treatment-planning stage, not after complications arise.
Why does WDI strongly emphasize indications and criteria for procedure selection, especially in the esthetic zone?
Prof. Marzena Dominiak: Because WDI teaches decision-making, not protocol copying. Immediate and delayed implant placement are discussed not as technical alternatives, but as clinical decisions dependent on biological conditions, soft-tissue stability, and long-term expectations. Treatment success results from proper case selection — not mechanical adherence to a single protocol.
What role does soft-tissue management play in the WDI program?
Prof. Marzena Dominiak: WDI integrates hard- and soft-tissue surgery into a single clinical concept. The program covers comprehensive soft-tissue management — from the first incision and flap design through angiogenesis control to final suturing and tissue stabilization. In bone regeneration and implant therapy, we emphasize that long-term stability depends not only on bone volume, but on the quality and preservation of soft tissues.
Does WDI aim to simplify rather than expand clinical knowledge?
Prof. Marzena Dominiak: Absolutely. The goal is not to know more procedures, but to know when not to use them. We organize knowledge instead of multiplying it, focusing on clear selection criteria, precise treatment protocols, proper timing, and well-defined indications and contraindications. We consistently return to the fundamental questions: when, why, and in whom?
Can WDI be seen as a platform for honest discussion about the limits of implantology?
Prof. Marzena Dominiak: Yes. We deliberately create space for discussing the boundaries of implant treatment effectiveness rather than masking them. Progress in implantology depends on the ability to anticipate and limit complications, not to ignore them. We discuss peri-implantitis in terms of “what we know and what we do not know,” presenting real clinical outcomes rather than a narrative of “100% success rates.”
Does WDI divide clinicians into “beginners” and “advanced”?
Prof. Marzena Dominiak: No. We unite clinicians around a shared language of biology and responsible decision-making. Experience in implantology is not measured solely by the number of procedures performed, but by the quality of clinical decisions. While the agenda includes highly advanced topics, knowledge is delivered step by step — particularly in the workshop format.
Should implantology increasingly incorporate broader perspectives on patient systemic health?
Prof. Marzena Dominiak: Definitely. Treatment success depends not only on technique or materials, but also on the patient’s general health and inflammatory and metabolic processes. This includes chronic inflammation, impaired regeneration, and peri-implantitis. Broadening the role of dentistry in prevention and early identification of systemic risk factors will increasingly shape both scientific reflection and clinical practice.
So WDI is not just another implantology conference.
Prof. Marzena Dominiak: Certainly not. WDI is an expression of the implantology community’s responsibility for treatment quality and patient safety. The program emphasizes evidence-based medicine, rational antibiotic therapy, and long-term treatment stability rather than short-term effects. Preventing complications is a priority, because decisions made at the planning stage have the greatest impact on durability and safety. Implantology education today is not about novelty — it is about responsibility. See you in Wroclaw!